Crystallization and X-ray diffraction analysis of the N-terminal domain of the Toll-like receptor signalling adaptor protein TRIF/TICAM-1

Acta Crystallographica Section F: Structural Biology and Crystallization Communications

Volumn 69, Issue 7, 2013, Pages 766-770

  Ullah, M Obayed ^a   Ve, Thomas ^a   Dkhar, Jameris ^a   Alaidarous, Mohammed ^a   Ericsson, Daniel J ^a   Sweet, Matthew J ^a   Mansell, Ashley ^b   Kobe, Bostjan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

adaptor proteins; innate immunity; introduction of additional methionine residues; selenomethionine labelling; Toll like receptors

Indexed keywords

ADAPTOR PROTEIN; MUTANT PROTEIN; SELENOMETHIONINE; TICAM1 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CRYSTALLIZATION; ENZYME ACTIVE SITE; GENETICS; HUMAN; INNATE IMMUNITY; INTRODUCTION OF ADDITIONAL METHIONINE RESIDUES; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SELENOMETHIONINE LABELLING; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

ADAPTOR PROTEINS; INNATE IMMUNITY; INTRODUCTION OF ADDITIONAL METHIONINE RESIDUES; SELENOMETHIONINE LABELLING; TOLL-LIKE RECEPTORS;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; CATALYTIC DOMAIN; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PROTEIN STRUCTURE, TERTIARY; SELENOMETHIONINE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84880110525     PISSN: None     EISSN: 17443091     Source Type: Journal    
DOI: 10.1107/S174430911301419X     Document Type: Article

References (19)

1. Akira, S., Uematsu, S. & Takeuchi, O. (2006). Cell, 124, 783-801.
2. Evans, P. (2006). Acta Cryst. D62, 72-82.
3. Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M. & Golenbock, D. T. (2003). J. Exp. Med. 198, 1043-1055.
4. Gay, N. J. & Gangloff, M. (2007). Annu. Rev. Biochem. 76, 141-165.
5. Kabsch, W. (2010). Acta Cryst. D66, 125-132.
6. Kaiser, W. J. & Offermann, M. K. (2005). J. Immunol. 174, 4942-4952.
7. Kantardjieff, K. A. & Rupp, B. (2003). Protein Sci. 12, 1865-1871.
8. Leslie, A. G.W. & Powell, H. R. (2007). EvolvingMethods for Macromolecular Crystallography, edited by R. Read & J. L. Sussman, pp. 41-51. Dordrecht: Springer.
9. Matthews, B. W. (1968). J. Mol. Biol. 33, 491-497.
10. O'Neill, L. A. & Bowie, A. G. (2007). Nature Rev. Immunol. 7, 353- 364.
11. Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T. & Seya, T. (2003). Nature Immunol. 4, 161-167.
12. Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M. & Seya, T. (2003). J. Biol. Chem. 278, 49751-49762.
13. Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K. & Akira, S. (2003). J. Immunol. 171, 4304-4310.
14. Stols, L., Gu, M., Dieckman, L., Raffen, R., Collart, F. R. & Donnelly, M. I. (2002). Protein Expr. Purif. 25, 8-15.
15. Studier, F. W. (2005). Protein Expr. Purif. 41, 207-234.
16. Tatematsu, M., Ishii, A., Oshiumi, H., Horiuchi, M., Inagaki, F., Seya, T. & Matsumoto, M. (2010). J. Biol. Chem. 285, 20128-20136.
17. Ve, T., Gay, N. J., Mansell, A., Kobe, B. & Kellie, S. (2012). Curr. Drug Targets, 13, 1360-1374.
18. Winn, M. D. et al. (2011). Acta Cryst. D67, 235-242.
19. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K. & Akira, S. (2003). Science, 301, 640-643.